Pragma Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$9.7M
- Investors
-
22
Pragma Bio General Information
Description
Developer of a biotechnology machine learning platform intended to discover and develop small molecules, drawing on novel insights from human-associated bacteria. The company involves tapping into bacterial genes to identify health-indicative small molecules, providing a more favorable starting point for developing innovative medicines and the methods offer an efficient and context-rich alternative to traditional drug discovery techniques, positioning at the forefront of delivering improved medicines to patients more quickly and cost-effectively, specializing in the gut-immune axis, employ real-world data, artificial intelligence/machine learning, and synthetic biology to uncover new medicines with robust safety profiles, an accelerated path to in vivo efficacy, and de-risked biology at each stage of the discovery process, enabling clinicians to better serve their patients.
Contact Information
Website
www.pragmabio.comCorporate Office
- 280 Utah Avenue
- Suite 110
- South San Francisco, CA 94080
- United States
Corporate Office
- 280 Utah Avenue
- Suite 110
- South San Francisco, CA 94080
- United States
Pragma Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A1) | 01-Sep-2022 | $9.7M | Completed | Startup | ||
| 7. Early Stage VC (Series A) | 18-Oct-2020 | Completed | Startup | |||
| 6. Accelerator/Incubator | 09-Oct-2020 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 21-Mar-2019 | Completed | Startup | |||
| 4. Grant | 12-Mar-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 17-Oct-2018 | Completed | Startup | |||
| 2. Grant | 17-May-2018 | $15K | Completed | Startup | ||
| 1. Grant | 24-Apr-2018 | $50K | Completed | Startup |
Pragma Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Series A-3 | ||||||||
| Series A-4 | ||||||||
| Series A-5 | 2,030,032 | $0.000010 | 8% | $0.89 | $0.89 | 1x | $0.89 | 13% |
| Series A-5 | 1,219,511 | $0.000010 | 8% | $0.41 | $0.41 | 1x | $0.41 | 7.81% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pragma Bio Comparisons
Industry
Financing
Details
Pragma Bio Competitors (45)
One of Pragma Bio’s 45 competitors is Second Genome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Second Genome | Formerly VC-backed | Brisbane, CA | ||||
| Hexagon Bio | Venture Capital-Backed | Menlo Park, CA | ||||
| BenevolentAI | Formerly PE-Backed | London, United Kingdom | ||||
| AbCellera | Formerly VC-backed | Vancouver, Canada | ||||
| Adapsyn | Venture Capital-Backed | Hamilton, Canada |
Pragma Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pragma Bio Patents
Pragma Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4305191-A1 | Systems and methods for identifying microbial biosynthetic genetic clusters | Pending | 12-Mar-2021 | ||
| US-20240153588-A1 | Systems and methods for identifying microbial biosynthetic genetic clusters | Pending | 12-Mar-2021 | ||
| EP-4305191-A4 | Systems and methods for identifying microbial biosynthetic genetic clusters | Pending | 12-Mar-2021 | G16B30/10 |
Pragma Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pragma Bio Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3CC | Third Culture Capital | Venture Capital | Minority | ||
| The Venture Collective | Venture Capital | Minority | ||
| Bioverge Ventures | Venture Capital | Minority | ||
| CJ Investment | Corporate Venture Capital | Minority | ||
| CRCM Ventures | Venture Capital | Minority |
Pragma Bio FAQs
-
When was Pragma Bio founded?
Pragma Bio was founded in 2018.
-
Where is Pragma Bio headquartered?
Pragma Bio is headquartered in South San Francisco, CA.
-
What is the size of Pragma Bio?
Pragma Bio has 26 total employees.
-
What industry is Pragma Bio in?
Pragma Bio’s primary industry is Drug Discovery.
-
Is Pragma Bio a private or public company?
Pragma Bio is a Private company.
-
What is the current valuation of Pragma Bio?
The current valuation of Pragma Bio is .
-
What is Pragma Bio’s current revenue?
The current revenue for Pragma Bio is .
-
How much funding has Pragma Bio raised over time?
Pragma Bio has raised $14.2M.
-
Who are Pragma Bio’s investors?
3CC | Third Culture Capital, The Venture Collective, Bioverge Ventures, CJ Investment, and CRCM Ventures are 5 of 22 investors who have invested in Pragma Bio.
-
Who are Pragma Bio’s competitors?
Second Genome, Hexagon Bio, BenevolentAI, AbCellera, and Adapsyn are some of the 45 competitors of Pragma Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
